Daniel Remick, M.D.
Chair and Professor of Pathology and Laboratory Medicine
Boston University School of Medicine and Boston Medical Center
Liliana Guedez, Ph.D.
Senior Clinical Scientist
Laboratory of Immunology
National Eye Institute
|Related Scientific Literature|
ASIP Members are invited to participate in the Biobanking SIG Listserv. Please email Constanza Bacon, at the ASIP main office to have your name and email address added to the listserv.
To send a message to the Biobanking SIG Listserv, send your email to email@example.com. Please note that you must be a member of this listserv to send and receive messages.
Repositories of human biospecimens are valuable resources for the advancement and clinical translation of biomedical research, and they play a critical role in providing services for patient care. Biobanking of human specimens involves regulatory, ethical, and legal aspects in addition to the challenges related to pathology best practices in patient care and the procurement of quality specimens for research.
One of the challenges for biobanking is the availability of high-quality and histological validated biospecimens that allow the application of a full range of downstream analyses to advance our understanding of the genetic and molecular bases of disease. In this context, experimental and clinical pathologists should play a key role in advancing biospecimen science by developing standardized protocols for the collection, management, storage, and shipment of different human specimens. Thus, the mission of the Biobanking Scientific Interest Group is to advance our understanding of the requirements for the collection of different human specimens, identify those pre-analytical variables that affect biospecimen quality, and develop methods to decrease biospecimen variability and optimize long-term storage.
The objectives of the Biobanking Scientific Interest Group are to: